GeneDx Holdings (WGS) Market Capitalization (2020 - 2026)

GeneDx Holdings (WGS) has reported Market Capitalization for 7 consecutive years, with $2.0 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization fell 22.79% year-over-year to $2.0 billion in Q2 2026; TTM through Jun 2026 was $2.0 billion, a 22.79% decrease from a year earlier, with the FY2025 full-year figure at $3.8 billion, up 76.64% from the prior year.
• Market Capitalization was $2.0 billion for Q2 2026 at GeneDx Holdings, up from $1.9 billion in the prior quarter.
• Over five years, Market Capitalization peaked at $24.8 billion in Q1 2022 and troughed at $71.4 million in Q4 2023.
• A 5-year average of $2.8 billion and a median of $1.9 billion in 2022 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization slumped 99.03% in 2023 and soared 2914.13% in 2024, its largest moves.
• Over 5 years, Market Capitalization stood at $578.5 million in 2022, then tumbled by 87.65% to $71.4 million in 2023, then soared by 2914.13% to $2.2 billion in 2024, then surged by 76.64% to $3.8 billion in 2025, then slumped by 46.21% to $2.0 billion in 2026.
• The last three Market Capitalization figures came in at $2.0 billion (Q2 2026), $1.9 billion (Q1 2026), and $3.8 billion (Q4 2025), per Business Quant data.